Italia markets closed

ILMN Jan 2025 270.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
74,000,00 (0,00%)
Alla chiusura: 03:57PM EDT
Schermo intero
Chiusura precedente74,00
Aperto73,90
Denaro85,70
Lettera91,00
Prezzo d'esercizio270,00
Scadenza2025-01-17
Min-Max giorno73,55 - 74,40
Contratto - Min-MaxN/D
Volume47
Open Interest63
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera